Background The provision of highly active antiretroviral therapy (HAART) in resource-limited
settings follows a public health approach, which is characterised by a limited number of …

Background Clinical, immunologic and virologic outcomes at large HIV/AIDS care clinics in
resource poor settings are poorly described beyond the first year of highly active …

Many countries in Africa are planning to provide highly active antiretroviral therapy (HAART)
to millions of people with acquired immune deficiency syndrome. This will be a highly …

Objectives To describe temporal trends in baseline clinical characteristics, initial treatment
regimens and monitoring of patients starting antiretroviral therapy (ART) in resource‐limited …

The purpose of this study was to assess the one-year efficacy of highly active antiretroviral
therapy (HAART) administered by general practitioners in a primary care community clinic in …

Background There are conflicting reports of antiretroviral therapy (ART) effectiveness
comparisons between primary healthcare (PHC) facilities and hospitals in low-income …

Objective. To define the long‐term (2–4 years) clinical and virological outcome of an
antiretroviral treatment (ART) programme in rural South Africa. Methods. We performed a …

OBJECTIVE: To describe province-wide outcomes and temporal trends of the Western Cape
Province antiretroviral treatment (ART) programme 5 years since inception, and to …

Background Four studies from sub-Saharan Africa have found a substantial population-level
effect of ART provision on adult mortality. It is important to see if the impact changes with …

Background The roll-out of antiretroviral therapy (ART) in Africa will have significant
resource implications arising from its impact on demand for healthcare services. Existing …